MedPath

i-SENS, Inc.

πŸ‡°πŸ‡·South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:4

Trial Phases

1 Phases

Not Applicable:7

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
7 (100.0%)

Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / Ξ²-Ketone System

Not Applicable
Terminated
Conditions
Diabetes
First Posted Date
2023-04-27
Last Posted Date
2024-02-29
Lead Sponsor
i-SENS, Inc.
Target Recruit Count
76
Registration Number
NCT05833100
Locations
πŸ‡ΊπŸ‡Έ

Rainier Clinical Research Center, Renton, Washington, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.